Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Oct 02, 2026
AXT, Inc. (AXTI) Climbs +44% in 30 Days on Rising AI Demand

AXT, Inc. (AXTI) Climbs +44% in 30 Days on Rising AI Demand

Key Takeaways

  • AXTI climbed roughly 44% over the trailing 30 days, rising from $56.95 on September 2, 2026 to $81.81 at the October 1, 2026 close.
  • The advance reflects accelerating demand for indium phosphide (InP) substrates tied to AI data-center connectivity and silicon photonics, a market where AXT holds a strong position.
  • Fundamentals have improved sharply: non-GAAP gross margin reached 29.9% in the first quarter of 2026, and the company's InP backlog has surpassed $100 million.
  • Analyst consensus remains Buy, with an average price target near $91.60, while management has guided toward profitability and a doubling of InP capacity.
  • Key risks include concentrated manufacturing in China and the timing of Chinese export permits for indium phosphide, which have historically caused revenue swings.

AXT, Inc. (AXTI): Company Overview and Market Position

AXT, Inc. (AXTI) is a materials-science company headquartered in Fremont, California, that develops and manufactures high-performance compound and single-element semiconductor substrates, including indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge). These wafers are used where standard silicon substrates cannot meet the performance requirements of semiconductor and optoelectronic devices, serving end markets such as AI/data-center connectivity and silicon photonics, 5G infrastructure, passive optical networks, lasers, sensors, LED lighting, power amplifiers, and satellite solar cells.

AXT's manufacturing operations are based in China, and the company maintains a vertically integrated supply chain through partial ownership in more than ten Chinese companies that produce raw materials such as purified gallium and crucibles. Investors follow the stock closely as a leveraged play on the AI-driven optical and high-speed connectivity buildout, where indium phosphide is a critical enabling material. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Performance: Last 30 Days vs. Quarter

Over the last 30 days, AXTI advanced from $56.95 at the September 2, 2026 close to $81.81 at the October 1, 2026 close, a gain of approximately $24.86 per share, or roughly 44%. The move was punctuated by notable single-session swings, including a strong rally from the low-$57 range in mid-September into the low-$70s, followed by continued strength into the end of the month.

The quarterly picture is broadly similar on a net basis but far more volatile. From about $56.62 at the start of July, the shares have risen roughly 45% to current levels. That headline gain, however, masks a choppy path: a sharp July selloff toward the $37 area, a powerful August surge to intraday highs near $96, a pullback into the mid-$50s by early September, and the subsequent recovery through late September and early October. From what I see, the pattern highlights both opportunity and the need for careful position sizing.

Drivers Behind the Recent 30-Day Rally

The most important driver behind the recent move is the company's exposure to the AI infrastructure cycle. AXT's indium phosphide substrates are a core input for the high-speed optical connectivity used in data centers, and sustained hyperscaler spending has reinforced demand expectations. Analysts have responded with upward earnings-estimate revisions, and the consensus view remains Buy with an average target price near $91.60.

Company activity during the period also kept the stock in focus. AXT participated in multiple investor conferences, including the B. Riley Securities Consumer & TMT Conference in September and Morgan Stanley's Asia Best Corporate Day, and announced that it would report third-quarter 2026 results on October 29. Management's messaging around a record InP backlog exceeding $100 million, improving margins, and plans to double InP capacity continued to support the bullish narrative. The final trading session of the period added further momentum, with the stock rising more than 5% in a single day. I’m watching this closely as earnings approach.

Quarterly Performance Drivers

The multi-month trend has been defined by a fundamental inflection. First-quarter 2026 results, reported in late April, showed revenue rising about 39% year over year to $26.9 million, a sharp improvement in non-GAAP gross margin to 29.9% from 21.5% in the prior quarter, and a smaller-than-expected net loss. Management guided toward profitability and a doubling of indium phosphide capacity in the second half of the year, with plans to double it again in 2027.

Offsetting these positives, the quarter has also featured bouts of volatility tied to the timing of export permits issued by China's Ministry of Commerce for indium phosphide, as well as broader sensitivity to U.S.-China geopolitical tensions. These factors contributed to the sharp July selloff and have kept the stock's trading range unusually wide even as the dominant trend has been higher.

What to Watch Next for AXTI Stock

Looking ahead, the most immediate catalyst is AXT's third-quarter 2026 earnings report, scheduled for October 29, which will clarify whether demand, margins, and the pace of capacity expansion remain on track. Investors should also monitor the flow of Chinese export permits for indium phosphide, as any disruption has historically moved revenue and the share price. Additional factors include progress on the planned STAR Market listing of the company's Tongmei subsidiary, continued AI-related optical demand from hyperscalers, pricing and utilization trends in the manufacturing base, and the broader trajectory of the semiconductor cycle amid U.S.-China trade dynamics.

Exploring Tickeron’s Trending AI Robots

In my view, one useful way to stay on top of shifting market dynamics is to review Tickeron’s Trending AI Robots page. It offers a curated view of AI-powered trading bots designed to help traders and investors monitor market opportunities. Tickeron operates hundreds of AI trading bots that collectively trade thousands of tickers, but only the top-performing and most relevant bots are featured. The bots vary widely in strategy, timeframe, and performance metrics, allowing users to explore approaches ranging from short-term signals to longer-horizon trend-following systems. For those looking to complement their own research with data-driven, automated analysis, the page provides a straightforward way to review which strategies are currently gaining traction.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXTI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AXTI in upward trend: price rose above 50-day moving average on September 16, 2026

AXTI moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend. In 44 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on AXTI as a result. In 67 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for AXTI just turned positive on September 17, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

The 10-day moving average for AXTI crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +8.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 221 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

AXTI broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AXTI entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.467) is normal, around the industry mean (8.078). AXTI's P/E Ratio (2455.833) is considerably higher than the industry average of (161.623). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.801). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.66B. The market cap for tickers in the group ranges from 326.86K to 671.68B. ASML holds the highest valuation in this group at 671.68B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 29%. ACLS experienced the highest price growth at 18%, while TRT experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 4%. For the same stocks of the Industry, the average monthly volume growth was -23% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 34
Price Growth Rating: 44
SMR Rating: 71
Profit Risk Rating: 60
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
AXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufactures of high-performance compound semiconductor substrates

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
4281 Technology Drive
Phone
+1 510 438-4700
Employees
1072
Web
http://www.axt.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.